Eclipse gets conditional $20 million equity boost:
This article was originally published in Clinica
Executive Summary
Eclipse Surgical Technologies has gained a commitment from Acqua Wellington North American Equities for equity financing of up to $20 million, based on its share price performance over the next 15 months. The money will provide working capital for the Sunnyvale, California company as it moves towards an anticipated FDA approval for its transmyocardial revascularisation laser therapy. Acqua Wellington invests in small and mid-cap public companies focusing on life sciences and technology.